Repligen (RGEN) Construction in Progress (2011 - 2025)
Repligen (RGEN) posted quarterly Construction in Progress of $28.4 million for Q4 2025, up 0.67% year-over-year from $28.2 million in Q4 2024, and up 12.93% quarter-over-quarter from $25.1 million in Q3 2025.
Repligen (RGEN) Construction in Progress (2011 - 2025) Analysis & Trends
Repligen (RGEN) has reported Construction in Progress for 15 consecutive years, with $28.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Construction in Progress rose 0.67% year-over-year to $28.4 million; the TTM figure through Dec 2025 stood at $28.4 million (up 0.67% YoY), while the FY2025 annual figure was $28.4 million, up 0.67% from the prior year.
- Construction in Progress advanced to $28.4 million in Q4 2025 per RGEN's latest filing, from $25.1 million in the prior quarter.
- Across five years, Construction in Progress topped out at $77.8 million in Q2 2022 and bottomed at $7.9 million in Q2 2021.
- Historically, Construction in Progress has averaged $36.3 million across 5 years, with a median of $31.3 million in 2022.
- Annual changes were most pronounced in 2022 — Construction in Progress jumped 879.69% — and 2023, when it tumbled 60.05%.
- Repligen's Construction in Progress stood at $38.4 million in 2021, then fell by 17.93% to $31.6 million in 2022, then jumped by 49.23% to $47.1 million in 2023, then slumped by 40.09% to $28.2 million in 2024, then grew by 0.67% to $28.4 million in 2025.
- Business Quant data shows RGEN's Construction in Progress at $28.4 million in Q4 2025, $25.1 million in Q3 2025, and $25.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.37 Bn | 129.15 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.52 Bn | 51.66 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.73 Bn | 34.38 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.65 Bn | 32.18 Bn | 861.22 Mn | - |
| 5 | Medline | 29.14 Bn | 26.47 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.08 Bn | 24.64 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.59 Bn | 11.44 Bn | 1.03 Bn | - |
| 10 | Repligen | 10.23 Bn | 9.21 Bn | 110.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.40 Mn |
| Sep 30, 2025 | 25.15 Mn |
| Jun 30, 2025 | 25.94 Mn |
| Mar 31, 2025 | 25.49 Mn |
| Dec 31, 2024 | 28.21 Mn |
| Sep 30, 2024 | 40.24 Mn |
| Jun 30, 2024 | 54.33 Mn |
| Mar 31, 2024 | 53.07 Mn |
| Dec 31, 2023 | 47.09 Mn |
| Sep 30, 2023 | 37.68 Mn |
| Jun 30, 2023 | 31.08 Mn |
| Mar 31, 2023 | 30.89 Mn |
| Dec 31, 2022 | 31.55 Mn |
| Sep 30, 2022 | 53.45 Mn |
| Jun 30, 2022 | 77.81 Mn |
| Mar 31, 2022 | 54.34 Mn |
| Dec 31, 2021 | 38.45 Mn |
| Sep 30, 2021 | 14.72 Mn |
| Jun 30, 2021 | 7.94 Mn |
| Mar 31, 2021 | 19.35 Mn |